Cardiovascular outcome of glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitor on end-stage kidney disease patients with heart failure: an emulated target trial in patients with diabetes. (nature.com)

Authors: Liu PY … Sung JM Journal: Nature Communications Published: 2026-07-30 DOI: https://doi.org/10.1038/s41467-026-76083-5